Measuring importance of outcomes to patients: a cross-sectional survey for the German anal cancer guideline.

[1]  A. Jemal,et al.  Cancer statistics, 2020 , 2020, CA: a cancer journal for clinicians.

[2]  Sara T Brookes,et al.  A core outcome set for clinical trials of chemoradiotherapy interventions for anal cancer (CORMAC): a patient and health-care professional consensus. , 2018, The lancet. Gastroenterology & hepatology.

[3]  S. J. Henley,et al.  Trends in Human Papillomavirus–Associated Cancers — United States, 1999–2015 , 2018, MMWR. Morbidity and mortality weekly report.

[4]  J. Meyerhardt,et al.  Anal Carcinoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. , 2018, Journal of the National Comprehensive Cancer Network : JNCCN.

[5]  G. Guyatt,et al.  GRADE guidelines: 20. Assessing the certainty of evidence in the importance of outcomes or values and preferences-inconsistency, imprecision, and other domains. , 2018, Journal of clinical epidemiology.

[6]  A. Renehan,et al.  Systematic review of outcome measures following chemoradiotherapy for the treatment of anal cancer (CORMAC) , 2018, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[7]  Gordon H. Guyatt,et al.  GRADE Guidelines: 19. Assessing the certainty of evidence in the importance of outcomes or values and preferences-Risk of bias and indirectness. , 2018, Journal of clinical epidemiology.

[8]  Eva Ardanaz,et al.  Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study. , 2017, The Lancet. Oncology.

[9]  V. Goh,et al.  Association of Coloproctology of Great Britain & Ireland (ACPGBI): Guidelines for the Management of Cancer of the Colon, Rectum and Anus (2017) – Multidisciplinary Management , 2017, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[10]  V. Goh,et al.  Association of Coloproctology of Great Britain & Ireland (ACPGBI): Guidelines for the Management of Cancer of the Colon, Rectum and Anus (2017) – Anal Cancer , 2017, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[11]  M. Ducreux,et al.  Anal cancer: French Intergroup Clinical Practice Guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SNFCP). , 2017, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[12]  E. Akl,et al.  Using patient values and preferences to inform the importance of health outcomes in practice guideline development following the GRADE approach , 2017, Health and Quality of Life Outcomes.

[13]  R. Glynne-Jones,et al.  Clinical endpoints in trials of chemoradiation for patients with anal cancer. , 2017, The Lancet. Oncology.

[14]  A. Jemal,et al.  International trends in anal cancer incidence rates. , 2016, International journal of epidemiology.

[15]  D. Sebag‐Montefiore,et al.  The rising incidence of anal cancer in England 1990–2010: a population‐based study , 2014, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[16]  V. Goh,et al.  Anal cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[17]  Glyn Elwyn,et al.  Stop the silent misdiagnosis: patients’ preferences matter , 2012, BMJ : British Medical Journal.

[18]  Gordon H Guyatt,et al.  GRADE guidelines: 2. Framing the question and deciding on important outcomes. , 2011, Journal of clinical epidemiology.

[19]  G. Guyatt,et al.  GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. , 2011, Journal of clinical epidemiology.

[20]  J. Hayes,et al.  What do patients with brain metastases from non-small cell lung cancer want from their treatment? , 2009, Palliative medicine.

[21]  M. Brundage,et al.  What do we know about facilitating patient communication in the cancer care setting? , 2005, Psycho-oncology.

[22]  P. Butow,et al.  Communication styles in the cancer consultation: preferences for a patient‐centred approach , 2000, Psycho-oncology.